Combined exercise and nutrition program for older adults with muscle loss
Combined Exercise and Nutrition Intervention for Sarcopenia in Patients With Hip Fracture: CENTERS； A Multicenter Randomized Controlled Trial
This study tests if a program that combines exercise and better nutrition can help older adults with muscle loss feel stronger and improve their quality of life compared to regular medical care.
Quick facts
| Phase | Not applicable |
|---|---|
| Study type | Interventional |
| Enrollment | 118 (estimated) |
| Ages | 65 Years to 90 Years |
| Sex | All |
| Sponsor | Seoul Bumin Hospital Academic / other |
| Locations | 1 site (Seoul) |
| Trial ID | NCT06654648 on ClinicalTrials.gov |
What this trial studies
This study evaluates the effects of a combined exercise and nutrition intervention on older adults suffering from sarcopenia. It is a randomized controlled trial comparing the outcomes of this intervention against conventional medical care. Key metrics such as handgrip strength, gait speed, muscle power, and quality of life will be assessed at baseline, 12 weeks, and 24 weeks post-intervention. The goal is to establish a standard protocol for treating sarcopenia through a multidisciplinary approach.
Who should consider this trial
Good fit: Ideal candidates are individuals aged 65 to 90 who meet the criteria for sarcopenia and have metabolic syndrome.
Not a fit: Patients with severe chronic diseases or conditions that prevent them from exercising will likely not benefit from this study.
Why it matters
Potential benefit: If successful, this intervention could significantly improve muscle function and quality of life for older adults with sarcopenia.
How similar studies have performed: Other studies have shown promising results with combined exercise and nutrition interventions in improving muscle function in elderly patients, indicating potential for success in this approach.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * patients older than 65 years and under 90 years * patients who meet the criteria for the Asian Working Group for Sarcopenia (AWGS) 2019 * patients who had metabolic syndrome Exclusion Criteria: * patients with less than estimated glomerular filtration rate (eGFR) 30 * patients with musculoskeletal or chronic lung disease incapable of exercise * patients with untreated or uncontrolled cardiovascular disease which may affect muscle mass or performing exercise * patients less than 5 years after treatment of malignant tumor * patients with liver cirrhosis, diabetes and other chronic disease * patients who cannot perform combined exercise nutrition intervention for other reasons
Where this trial is running
Seoul
- Seoul Bumin Hospital — Seoul, South Korea (Recruiting)
Study contacts
- Principal investigator: Yongchan Ha, phD — Bumin Hospital(Seoul)
- Study coordinator: Yongchan Ha, phD
- Email: hayongch@naver.com
- Phone: 01085218328
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.